FDA Clearance Tracker · P990023-S013
CELLUGEL OPHTHALMIC VISCOSURGICAL DEVICE (OVD)
Last checked: Nov 20, 2026Latest source record: Feb 18, 2016 (this decision)Source: openFDAMethods & limitations
Decided
Feb 18, 2016
Approved
Time to decision
301 days
Received Apr 23, 2015. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P990023-S013
- Device name
- CELLUGEL OPHTHALMIC VISCOSURGICAL DEVICE (OVD)
- Applicant
- Alcon Laboratories
- Applicant location
- Fort Worth, TX
- Received
- Apr 23, 2015
- Decided
- Feb 18, 2016
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P990023
Device type
- Device type
- AID, SURGICAL, VISCOELASTIC (LZP)
- Device class
- Class III
- Regulation
- 21 CFR 886.4275
- Specialty
- Ophthalmology
FDA's approval statement
As written in FDA's record.
Approval for an alternate packaging configuration (syringe, rubber tip cap, pouch), change in the release specification for pH, and change in the release and stability specification for osmolality.
Source documents
Other decisions for Alcon Laboratories
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K254052 · Decided Feb 13, 2026 · 58 days after receipt
Device type: Lenses, Soft Contact, Daily Wear (LPL) · Ophthalmology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.